CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely vision-impaired and blind patients, a randomized clinical trial showed. After ...
Can eye exercises really improve your vision? Discover the truth behind eye workouts, their benefits, limitations, and expert ...
The Federal Trade Commission (FTC) has charged the marketers of a vision improvement app, called UltimEyes, with deceptively claiming they their program was scientifically proven to improve the user's ...
NEW YORK CITY -- A form of light therapy led to durable improvement in visual acuity for patients with dry age-related macular degeneration, according to interim results from an ongoing randomized ...
Vision is one of the most important senses for human life. Eyes help us perceive the world, perform daily tasks, connect with others, and enjoy the beauty around us. Good eyesight supports both ...
Newly Listed Lenz Therapeutics' Vision Loss Experimental Drug Meets Primary Goal In Late-Stage Study
On Wednesday, LENZ Therapeutics Inc (NASDAQ:LENZ) released topline results from its Phase 3 CLARITY study of two investigational formulations of aceclidine, LNZ100 and LNZ101. Presbyopia is the ...
PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies ...
Nanoscope Therapeutics has agreed with the US Food and Drug Administration (FDA) on the design of its Phase III trial following a successful Phase II study of its gene therapy in Stargardt disease.
Both trials met the primary and secondary near vision improvement endpoints. Treatment with an aceclidine-based eye drop was found to improve near vision in patients with presbyopia, according to ...
The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was 100 times better after they received gene therapy to address the genetic ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. LNZ100, an aceclidine-based eye drop, demonstrated a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results